Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in human melanoma

被引：0
|
作者：
Silini, A. [1 ]
Ardinghi, C. [2 ]
Carraro, F. [2 ]
Naldini, A. [2 ]
Bani, M. R. [1 ]
Giavazzi, R. [1 ]
机构：
[1] Mario Negri Inst Pharmacol Res, Dept Oncol, Lab Biol & Therapy Metastasis, I-24100 Bergamo, Italy
[2] Univ Siena, Dept Physiol, I-53100 Siena, Italy
来源：
THROMBOSIS RESEARCH | 2007年 / 120卷
关键词：
D O I：
10.1016/S0049-3848(07)70148-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [21] Pharmacologic Profile of SCH 530348, a Novel Oral Antiplatelet Agent Selective for the Protease-Activated Receptor-1 (PAR-1)
    Chintala, Madhu
    Ahn, Ho-Sam
    Foster, Carolyn
    Agans, Jacqueline
    Boykow, George
    CIRCULATION, 2008, 118 (18) : S374 - S374
  • [22] Protease-activated receptor-1 (PAR-1) increases intracellular calcium and mediates chloride secretion in an epithelial cell line
    Buresi, MC
    Schleihauf, E
    Vergnolle, N
    Chapman, K
    Buret, A
    Wallace, JL
    Hollenberg, MD
    MacNaughton, WK
    FASEB JOURNAL, 2000, 14 (04): : A114 - A114
  • [23] Protease-activated receptor-1 at the synapse
    Shavit-Stein, E.
    Katzev, A.
    Chapman, J.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (SUPPL 1) : S108 - S108
  • [24] Suppression of ischaemia-induced injuries in rat brain by protease-activated receptor-1 (PAR-1) activating peptide
    Zhen, Xia
    Ng, Ethel Sau Kuen
    Lam, Francis Fu Yuen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 786 : 36 - 46
  • [25] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis
    Lin, C.
    Aberson, H. L.
    Von der Thusen, J.
    Borensztajn, K.
    Spek, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [27] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Yamaguchi, Akio
    ANTICANCER RESEARCH, 2008, 28 (2A) : 847 - 854
  • [28] Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes
    Junge, CE
    Lee, CJ
    Hubbard, KB
    Zhang, ZB
    Olson, JJ
    Hepler, JR
    Brat, DJ
    Traynelis, SF
    EXPERIMENTAL NEUROLOGY, 2004, 188 (01) : 94 - 103
  • [29] Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats
    Andrade-Gordon, P
    Derian, CK
    Maryanoff, BE
    Zhang, HC
    Addo, MF
    Cheung, WM
    Damiano, BP
    D'Andrea, MR
    Darrow, AL
    De Garavilla, L
    Eckardt, AJ
    Giardino, EC
    Haertlein, BJ
    McComsey, DF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 34 - 42
  • [30] The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
    Nilsen, Dennis W. T.
    Roysland, Michelle
    Ueland, Thor
    Aukrust, Pal
    Michelsen, Annika E.
    Staines, Harry
    Barvik, Stale
    Kontny, Frederic
    Nordrehaug, Jan Erik
    Bonarjee, Vernon V. S.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 510 - 521
12345